These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 26117478)
41. Management of pediatric multidrug-resistant tuberculosis and latent tuberculosis infections in New York City from 1995 to 2003. Feja K; McNelley E; Tran CS; Burzynski J; Saiman L Pediatr Infect Dis J; 2008 Oct; 27(10):907-12. PubMed ID: 18756183 [TBL] [Abstract][Full Text] [Related]
42. Highly successful treatment outcome of multidrug-resistant tuberculosis in the Netherlands, 2000-2009. van Altena R; de Vries G; Haar CH; de Lange WC; Magis-Escurra C; van den Hof S; van Soolingen D; Boeree MJ; van der Werf TS Int J Tuberc Lung Dis; 2015 Apr; 19(4):406-12. PubMed ID: 25859995 [TBL] [Abstract][Full Text] [Related]
43. Outcome of treatment of MDR-TB patients with standardised regimens, Iran, 2002-2006. Masjedi MR; Tabarsi P; Chitsaz E; Baghaei P; Mirsaeidi M; Amiri MV; Farnia P; Javanmard P; Mansouri D; Velayati AA Int J Tuberc Lung Dis; 2008 Jul; 12(7):750-5. PubMed ID: 18544199 [TBL] [Abstract][Full Text] [Related]
44. Drug-resistant tuberculosis in Israel: risk factors and treatment outcomes. Mor Z; Goldblatt D; Kaidar-Shwartz H; Cedar N; Rorman E; Chemtob D Int J Tuberc Lung Dis; 2014 Oct; 18(10):1195-201. PubMed ID: 25216833 [TBL] [Abstract][Full Text] [Related]
45. Early detection of multi-drug resistance and common mutations in Mycobacterium tuberculosis isolates from Delhi using GenoType MTBDRplus assay. Singhal R; Myneedu VP; Arora J; Singh N; Bhalla M; Verma A; Sarin R Indian J Med Microbiol; 2015 Feb; 33 Suppl():46-52. PubMed ID: 25657156 [TBL] [Abstract][Full Text] [Related]
46. [Frequency of drug resistant tuberculosis in Poland in 2000 as compared to 1997]. Augustynowicz-Kopeć E; Zwolska Z; Jaworski A; Kostrzewa E; Klatt M; Swiderska A; Drozd I Pneumonol Alergol Pol; 2002; 70(3-4):193-202. PubMed ID: 12271966 [TBL] [Abstract][Full Text] [Related]
47. 'I cry every day': experiences of patients co-infected with HIV and multidrug-resistant tuberculosis. Isaakidis P; Rangan S; Pradhan A; Ladomirska J; Reid T; Kielmann K Trop Med Int Health; 2013 Sep; 18(9):1128-1133. PubMed ID: 23837468 [TBL] [Abstract][Full Text] [Related]
48. Multidrug-resistant tuberculosis in New South Wales, Australia, 1999-2010: a case series report. Roberts-Witteveen A; Reinten T; Christensen A; Sintchenko V; Seale P; Lowbridge C Int J Tuberc Lung Dis; 2015 Jul; 19(7):850-6. PubMed ID: 26056113 [TBL] [Abstract][Full Text] [Related]
49. Efficacy of a new model for delivering integrated TB and HIV services for people living with HIV/AIDS in Delhi -- case for a paradigm shift in national HIV/TB cross-referral strategy. Gupta AK; Singh GP; Goel S; Kaushik PB; Joshi BC; Chakraborty S AIDS Care; 2014 Feb; 26(2):137-41. PubMed ID: 24364397 [TBL] [Abstract][Full Text] [Related]
50. Predictors of recurrence of multidrug-resistant and extensively drug-resistant tuberculosis. Blöndal K; Viiklepp P; Guðmundsson LJ; Altraja A Int J Tuberc Lung Dis; 2012 Sep; 16(9):1228-33. PubMed ID: 22748131 [TBL] [Abstract][Full Text] [Related]
51. Decline in rates of acquired multidrug-resistant tuberculosis after implementation of the directly observed therapy, short course (DOTS) and DOTS-Plus programmes in Taiwan. Chien JY; Lai CC; Tan CK; Chien ST; Yu CJ; Hsueh PR J Antimicrob Chemother; 2013 Aug; 68(8):1910-6. PubMed ID: 23580558 [TBL] [Abstract][Full Text] [Related]
52. Effects of treatment interruption patterns on treatment success among patients with multidrug-resistant tuberculosis in Armenia and Abkhazia. Bastard M; Sanchez-Padilla E; Hewison C; Hayrapetyan A; Khurkhumal S; Varaine F; Bonnet M J Infect Dis; 2015 May; 211(10):1607-15. PubMed ID: 25312040 [TBL] [Abstract][Full Text] [Related]
53. Trends & treatment outcomes of multidrug-resistant tuberculosis in Delhi, India (2009-2014): A retrospective record-based study. Sharma N; Khanna A; Chandra S; Basu S; Chopra KK; Singla N; Babbar N; Kohli C Indian J Med Res; 2020 Jun; 151(6):598-603. PubMed ID: 32719234 [TBL] [Abstract][Full Text] [Related]
54. The importance of providing counselling and financial support to patients receiving treatment for multi-drug resistant TB: mixed method qualitative and pilot intervention studies. Baral SC; Aryal Y; Bhattrai R; King R; Newell JN BMC Public Health; 2014 Jan; 14():46. PubMed ID: 24438351 [TBL] [Abstract][Full Text] [Related]
55. Community-based MDR-TB care project improves treatment initiation in patients diagnosed with MDR-TB in Myanmar. Wai PP; Shewade HD; Kyaw NTT; Thein S; Si Thu A; Kyaw KWY; Aye NN; Phyo AM; Maung HMW; Soe KT; Aung ST PLoS One; 2018; 13(3):e0194087. PubMed ID: 29596434 [TBL] [Abstract][Full Text] [Related]
56. Factors affecting the treatment outcome of injection based shorter MDR-TB regimen at a referral centre in India. B K; Singla R; Singla N; V V; Singh K; Choudhury MP; Bhattacherjee N Monaldi Arch Chest Dis; 2022 Oct; 93(3):. PubMed ID: 36200688 [TBL] [Abstract][Full Text] [Related]
58. Linezolid in the treatment of MDR-TB: a retrospective clinical study. Xu HB; Jiang RH; Li L; Xiao HP Int J Tuberc Lung Dis; 2012; 16(3):358-63. PubMed ID: 22640450 [TBL] [Abstract][Full Text] [Related]
59. Factors contributing to the high prevalence of multidrug-resistant tuberculosis: a study from China. Liang L; Wu Q; Gao L; Hao Y; Liu C; Xie Y; Sun H; Yan X; Li F; Li H; Fang H; Ning N; Cui Y; Han L Thorax; 2012 Jul; 67(7):632-8. PubMed ID: 22403070 [TBL] [Abstract][Full Text] [Related]
60. Multi-drug-resistant tuberculosis: the experience of an urban tertiary care hospital in South India using automated BACTEC 460 TB. Mishra B; Rockey SM; Gupta S; Srinivasa H; Muralidharan S Trop Doct; 2012 Jan; 42(1):35-7. PubMed ID: 22080484 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]